CBD vs Ibuprofen — Why CBD Targets Four Inflammatory Pathways at Once
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainCBDResearchSafetyAgingDosingPolicy Why This Matters Clinicians should understand that CBD may modulate multiple…
THC/CBD Combination Cuts Agitation in Hospice-Eligible Dementia: LiBBY Trial
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyResearchTHCCBDAgingSafetyMental Health Why This Matters Clinicians treating advanced dementia patients with…
Clinical Trial: THC/CBD Formulation Reduces Alzheimer’s-Induced Agitation
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchTHCCBDNeurologyAgingMental HealthAnxiety Why This Matters This trial provides clinicians with potential…
New Studies Find Cannabis Reduces Alzheimer’s-Induced Agitation
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyAgingTHCCBDResearchMental HealthSafety Why This Matters Clinicians managing behavioral symptoms in…
Clinical Trial: THC/CBD Formulation Reduces Alzheimer’s-Induced Agitation
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyCBDTHCAgingMental HealthSafety Why This Matters Clinicians treating Alzheimer's disease patients…
Daily Cannabis News Brief: Cannabidiol and Intestinal Protection
Recent evidence highlights cannabidiol antioxidant intestinal protection as a key factor in improving gut health by reducing oxidative stress and inflammation. This clinical insight from 2026 cannabis research suggests potential therapeutic applications.…
Combination of THC and CBD eased symptoms in especially frail population. #HeraldPremium
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAgingSafetyDosingPain Why This Matters Clinicians treating frail patients with multiple comorbidities now…
Runner’s High Isn’t Endorphins
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyMental HealthSafetyPainAnxietyCBD Why This Matters Clinicians should understand that the euphoric…
Cannabinoids Fall Short Across Most Psychiatric Disorders
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Mental HealthResearchSafetyTHCCBDPediatricsAnxiety Why This Matters Clinicians should be aware that current evidence does…
Is VER-01 a Turning Point for Cannabis-Derived Medicines?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCSafetyNeurologyIndustryPain Why This Matters Clinicians need to understand that pharmaceutical cannabinoids…